BioCentury | Jul 14, 2017
Strategy

Back to Ipsen’s roots

...buy the company upon completion; SSTR2 = somatostatin receptor 2; NTSR1 = neurotensin receptor 1; KCNMB4...
BioCentury | Jun 29, 2017
Translation in Brief

New Therapeutic Targets and Biomarkers: June 2017

...subunit 4 (KCNMB4) Canbex Therapeutics Ltd. has VSN16R, a calcium-activated potassium (BKCa) channel activator targeting KCNMB4...
Items per page:
1 - 2 of 2